OneMedNet Corp Files 8-K/A Amendment
Ticker: ONMDW · Form: 8-K/A · Filed: Nov 22, 2024 · CIK: 1849380
Sentiment: neutral
Topics: amendment, financial-statements, exhibits
TL;DR
OneMedNet Corp filed an amendment to its 8-K, updating financial statements and exhibits.
AI Summary
OneMedNet Corp filed an amendment (8-K/A) on November 22, 2024, to its report originally dated November 7, 2023. This amendment pertains to financial statements and exhibits, with the date of change noted as November 22, 2024. The company was formerly known as Data Knights Acquisition Corp. until March 4, 2021.
Why It Matters
This filing is an amendment to a previous report, indicating a correction or addition to previously disclosed information, which could be material for investors.
Risk Assessment
Risk Level: low — This is a routine amendment filing for financial statements and exhibits, not indicating new material events.
Key Players & Entities
- OneMedNet Corp (company) — Registrant
- Data Knights Acquisition Corp. (company) — Former company name
- November 7, 2023 (date) — Original report date
- November 22, 2024 (date) — Filing date of amendment
- March 4, 2021 (date) — Date of name change
FAQ
What is the purpose of this 8-K/A filing?
This filing is an amendment (Amendment No. 1) to a previously filed Form 8-K, specifically related to Financial Statements and Exhibits.
When was the original report filed?
The original report was dated November 7, 2023.
What was OneMedNet Corp's former name?
OneMedNet Corp was formerly known as Data Knights Acquisition Corp.
When did the company change its name?
The company's name change from Data Knights Acquisition Corp. to OneMedNet Corporation occurred on March 4, 2021.
What is the filing date of this amendment?
This amendment (8-K/A) was filed as of November 22, 2024.
Filing Stats: 1,280 words · 5 min read · ~4 pages · Grade level 10.5 · Accepted 2024-11-22 16:15:39
Key Financial Figures
- $0.0001 — ge on which registered Common Stock, $0.0001 par value per share ONMD The Nasdaq
- $11.50 — of Common Stock at an exercise price of $11.50 per share ONMDW The Nasdaq Stock Ma
Filing Documents
- form8-ka.htm (8-K/A) — 63KB
- ex99-1.htm (EX-99.1) — 949KB
- ex99-3.htm (EX-99.3) — 276KB
- 0001493152-24-047380.txt ( ) — 5663KB
- onmt-20230930.xsd (EX-101.SCH) — 34KB
- onmt-20230930_cal.xml (EX-101.CAL) — 41KB
- onmt-20230930_def.xml (EX-101.DEF) — 225KB
- onmt-20230930_lab.xml (EX-101.LAB) — 318KB
- onmt-20230930_pre.xml (EX-101.PRE) — 270KB
- form8-ka_htm.xml (XML) — 887KB
Financial Statements of Business Acquired
Financial Statements of Business Acquired The consolidated financial statements of Legacy OneMedNet as of and for the three and nine months ended September 30, 2023, and the related notes thereto, are attached to this Amendment as Exhibit 99.1 and are incorporated herein by reference. Also attached as Exhibit 99.3 and incorporated herein by reference is the Management's Discussion and Analysis of Financial Condition and Results of Operations of Legacy OneMedNet as of and for the three and nine months ended September 30, 2023. (d) Exhibits Exhibit No. Description 2.1 Agreement and Plan of Merger, dated April 25, 2022, by and among Data Knights, Merger Sub, Sponsor, OneMedNet, and Paul Casey (incorporated by reference to Exhibit 2.1 to the Company's Form 8-K, filed with the SEC on April 25, 2022). 3.1* Third Amended and Restated Certificate of Incorporation of OneMedNet Corporation. 3.2* Amended and Restated Bylaws of OneMedNet Corporation. 4.1 Warrant Agreement, dated May 6, 2021, by and between Continental Stock Transfer & Trust Company and the Company (incorporated by reference to Exhibit 4.4 to the Company's Form S-1/A, filed with the SEC on April 7, 2021). 4.2 Specimen Unit Certificate (incorporated by reference to Exhibit 4.1 to the Company's Form S-1/A, filed with the SEC on April 7, 2021). 4.3 Specimen Class A Common Stock Certificate (incorporated by reference to Exhibit 4.2 to the Company's Form S-1/A, filed with the SEC on April 7, 2021). 4.4 Specimen Warrant Certificate (incorporated by reference to Exhibit 4.3 to the Company's Form S-1/A, filed with the SEC on April 7, 2021). 10.1+ Form of OneMedNet Corporation 2022 Equity Incentive Plan (incorporated by reference to Annex D to the proxy statement/prospectus which is part of the Registration Statement on Form S-4 declared effective by the SEC on September 22, 2023). 10.2 Form of Registration Rights Agreement by certain OneMedNet equity holders (included as Exh
Financial Statements for OneMedNet Corp for the three and nine months ended September 30, 2023
Financial Statements for OneMedNet Corp for the three and nine months ended September 30, 2023. 99.2* Unaudited pro forma condensed consolidated combined financial information for the six months ended June 30, 2023 and for the year ended December 31, 2022. 99.3** Management's Discussion and Analysis of Financial Condition and Results of Operations for OneMedNet Corp for the three and nine months ended September 30, 2023 . 99.4* Press Release dated November 8, 2023. 99.5* Press Release dated November 9, 2023 99.6* Press Release dated November 10, 2023 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). ** Filed herewith * Previously filed + Indicates a management or compensatory plan. Schedules to this exhibit have been omitted pursuant to Item 601(b)(2) of Registration S-K. The Registrant hereby agrees to furnish a copy of any omitted schedules to the SEC upon request. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: November 22, 2024 ONEMEDNET CORPORATION By: /s/ Aaron Green Aaron Green Chief Executive Officer